*sigh* very uneventful news and we've heard all this before, and quite rightfully the share price continues to bleed out towards sub $2. Disappointing really that there is no expected timeframe to meet with FDA on anything. They also continue to use the word 'may' when discussing trial results. Surely the treatment either will or won't do something, and there must come a time where 'may' is eliminated.
Ann: Mesoblast Operational Highlights and Upcoming Milestones, page-46
-
- There are more pages in this discussion • 132 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.124B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 96.0¢ | $1.742M | 1.787M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 42488 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 40461 | 11 |
View Market Depth
| Last trade - 11.01am 26/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |